SYMADINE Drug Patent Profile
✉ Email this page to a colleague
When do Symadine patents expire, and when can generic versions of Symadine launch?
Symadine is a drug marketed by Solvay and is included in one NDA.
The generic ingredient in SYMADINE is amantadine hydrochloride. There are seven drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the amantadine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Symadine
A generic version of SYMADINE was approved as amantadine hydrochloride by UPSHER SMITH LABS on August 5th, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SYMADINE?
- What are the global sales for SYMADINE?
- What is Average Wholesale Price for SYMADINE?
Summary for SYMADINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 2 |
| DailyMed Link: | SYMADINE at DailyMed |
Recent Clinical Trials for SYMADINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Columbia University | Phase 4 |
| Edward Hines Jr. VA Hospital | N/A |
US Patents and Regulatory Information for SYMADINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solvay | SYMADINE | amantadine hydrochloride | CAPSULE;ORAL | 071000-001 | Sep 4, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
